Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594523 | SCV000704957 | uncertain significance | not provided | 2017-01-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852033 | SCV002184690 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-04-29 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 1447 of the CC2D2A protein (p.Glu1447Ala). This variant is present in population databases (rs387907058, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with CC2D2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 30934). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV004532401 | SCV004119343 | uncertain significance | CC2D2A-related disorder | 2023-07-21 | criteria provided, single submitter | clinical testing | The CC2D2A c.4340A>C variant is predicted to result in the amino acid substitution p.Glu1447Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0066% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-15597733-A-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Gene |
RCV000594523 | SCV005373289 | likely pathogenic | not provided | 2024-04-03 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign in association with neurodevelopmental disorders to our knowledge; This variant is associated with the following publications: (PMID: 31964843) |
OMIM | RCV000023923 | SCV000045214 | pathogenic | Joubert syndrome 9/15, digenic | 2012-01-15 | no assertion criteria provided | literature only |